You have 9 free searches left this month | for more free features.

As2O3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Soccer Training, Body Composition, Physical Activity Trial in Tríkala (FIM-1, FIM-2, FIM-3)

Recruiting
  • Soccer Training
  • +3 more
  • FIM-1
  • +3 more
  • Tríkala, Greece
    University o Thessaly, School of Physical Education and Sports S
May 30, 2022

Leukemia Trial in Tianjin (DNR:, Ara-c)

Completed
  • Leukemia
  • Tianjin, Tianjin, China
  • +1 more
Aug 8, 2021

Arsenic Trioxide, p53 Mutations, Refractory Cancer Trial in Shanghai (Arsenic Trioxide)

Recruiting
  • Arsenic Trioxide
  • +3 more
  • Arsenic Trioxide
  • Shanghai, China
    Department of Medical Oncology, Shanghai Changzheng Hospital
Jan 4, 2021

Osteosarcoma Trial in Italy (Mifamurtide arm, 3 drugs arm)

Active, not recruiting
  • Osteosarcoma
  • Mifamurtide arm
  • 3 drugs arm
  • Candiolo, Torino, Italy
  • +10 more
Sep 16, 2022

Psoriasis Trial in Worldwide (Secikinumab)

Active, not recruiting
  • Psoriasis
  • Adrogué, Buenos Aires, Argentina
  • +80 more
Oct 14, 2022

Venous Leg Ulcer Trial in Worldwide (Venous Leg Ulcer Standard of Care with Granulox)

Active, not recruiting
  • Venous Leg Ulcer
  • Venous Leg Ulcer Standard of Care with Granulox
  • Split, Croatia
  • +26 more
Jan 16, 2023

Metastatic Pancreatic Cancer Trial in United States (Nab paclitaxel, Gemcitabine, Dociparstat)

Terminated
  • Metastatic Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Jun 2, 2022

Vasomotor Symptoms Associated With Menopause, Hot Flashes Trial in Worldwide (Elinzanetant (BAY3427080), Placebo)

Active, not recruiting
  • Vasomotor Symptoms Associated With Menopause
  • Hot Flashes
  • Elinzanetant (BAY3427080)
  • Placebo
  • Birmingham, Alabama
  • +98 more
Feb 2, 2023

Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)

Active, not recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Nedlands, Western Australia, Australia
  • +63 more
Nov 3, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

Cognitive Frailty Trial in Brescia (Experimental: Oxygen-Ozone (O2-O3), Active Comparator: Oxygen (O2), Placebo Comparator:

Active, not recruiting
  • Cognitive Frailty
  • Experimental: Oxygen-Ozone (O2-O3)
  • +2 more
  • Brescia, Italy
    IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
Oct 10, 2023

Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +91 more
Jan 18, 2023

Cataract Trial in Italy, Slovakia, Spain (Chloroprocaine 3%, Tetracaine 0.5%)

Completed
  • Cataract
  • Chloroprocaine 3%
  • Tetracaine 0.5%
  • Bologna, Italy
  • +26 more
Apr 19, 2021

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Rotator Cuff Tendinopathy Trial in Ankara (Ozone (O2-O3) injection, Corticosteroid injection)

Completed
  • Rotator Cuff Tendinopathy
  • Ozone (O2-O3) injection
  • Corticosteroid injection
  • Ankara, Cankaya, Turkey
    Merve Örücü Atar
Jun 13, 2022

Type2 Diabetes, Dyslipidemia Trial in Worldwide (K-877, Placebo)

Terminated
  • Type2 Diabetes
  • Dyslipidemia
  • Birmingham, Alabama
  • +887 more
Dec 20, 2022

Uterine Fibroids Trial in Worldwide (Vilaprisan (BAY1002670))

Completed
  • Uterine Fibroids
  • Vilaprisan (BAY1002670)
  • Blacktown, New South Wales, Australia
  • +139 more
Oct 29, 2021

Solid Tumor, Breast Cancer, Cancer of Head and Neck Trial in Worldwide (RO6874281, Trastuzumab, Cetuximab)

Completed
  • Solid Tumor
  • +2 more
  • Tucson, Arizona
  • +25 more
Nov 21, 2022

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Diabetic Foot Ulcer Trial in Germany, Italy, Poland (AUP1602-C, Placebo)

Recruiting
  • Diabetic Foot Ulcer
  • AUP1602-C
  • Placebo
  • Münster, Germany
  • +9 more
Oct 30, 2023

Cognitive Impairment, Bipolar Disorder, Depression Trial in Copenhagen (Altitude-like hypoxia (12% O2), Normoxia (20% O2),

Recruiting
  • Cognitive Impairment
  • +2 more
  • Altitude-like hypoxia (12% O2)
  • +3 more
  • Copenhagen, Capital Region Of Copenhagen, Denmark
    Neurocognition and Emotion in Affective Disorders (NEAD) Centre,
Nov 10, 2023

Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

Recruiting
  • Brain Cancer
  • [18F]fluoro-2-deoxy-D-glucose (FDG)
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 3, 2023

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab 800 mg in combination with pemetrexed / carboplatin
  • +3 more
  • Tucson, Arizona
  • +45 more
Oct 13, 2022